Login Register Cart 0
Generic placeholder image

Recent Advances in Anti-Infective Drug Discovery

Editor-in-Chief

ISSN (Print): 2772-4344
ISSN (Online): 2772-4352

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Perspective

Antimicrobial Stewardship Program: Time to be Focused in Speciality Settings of Leprosy Institute and Related Health Care Setup

Author(s): Pugazhenthan Thangaraju*, Hemasri Velmurugan and Sajitha Venkatesan

Volume 19, Issue 2, 2024

Published on: 11 May, 2023

Page: [90 - 94] Pages: 5

DOI: 10.2174/2772434418666230417114640

Price: $65

Abstract

Leprosy, often known as Hansen's disease is a contagious chronic infectious disease caused by Mycobacterium leprae (M. leprae). Our methodology is easily repeatable in tertiary care settings with diagnostic accuracy resources and staff capable of building a stewardship team. Comprehensive antimicrobial policies and programmes are required to properly alleviate the initial issue.

« Previous
Graphical Abstract

[1]
WHO Leprosy . 2021. Available From: https://www.who.int/health-topics/leprosy#tab=tab_1
[2]
Thangaraju P, Velmurugan H, Yella SST, Venkatesan S. vigilance needed in treating leprosy patients in accordance with WHO’s AWaRe Adv Anti-Infect Drug Discov 2022; 17(2): 95-102.
[http://dx.doi.org/10.2174/2772434417666220720111849] [PMID: 35864797]
[3]
National Health Portal 2021.Available From https://www.nhp.gov.in/disease/skin/leprosy
[4]
Lockwood DNJ, Penna GO, Lambert S, Pai VV, Walker SL. Safer and newer antimicrobial drugs for leprosy – time to test monthly ROM in an adequately powered randomised trial? Lepr Rev 2022; 93(2): 96-101.
[http://dx.doi.org/10.47276/lr.93.2.96]
[5]
WHO Guidelines for the diagnosis, treatment and prevention of leprosy 2019. Available from: https://apps.who.int/iris/bitstream/handle/10665/274127/9789290226383-eng.pdf(Accessed: April 8, 2022)
[6]
Thangaraju P, Kumar BA, Velmurugan H, Venkatesan S, Yella SST. Leprosy reactions: Clinical Pharmacologist perspective with repurposed medications. Infect Disord Drug Targets 2023; 23(2)e070922208607
[http://dx.doi.org/10.2174/1871526522666220907125114] [PMID: 36082854]
[7]
World Health Organization Available From: https://www.who.int/news-room/fact-sheets/detail/leprosy#:~:text=Leprosy%20is%20a%20curable%20disease,12%20months%20for%20MB%20cases (Accessed on Feb 25, 2023).
[8]
Thangaraju P, Velmurugan H, Neelambaran K, Venkatesan S. Time to be vigilant in contacts of leprosy for possible single-dose rifampicin. JAAD Case Rep 2022; 29: 100-1.
[http://dx.doi.org/10.1016/j.jdcr.2022.05.014] [PMID: 36212896]
[9]
CLTRI 2021. Available from: https://cltri.gov.in/about/default.html
[10]
RLTRI Aska, Orissa. 2021. Available From: https://main.mohfw.gov.in/sites/default/files/8951774737RTI%20Report%20of%20RLTRI%20ASKA%2C%20ORISSA_0.pdf
[11]
RLTRI . Raipur, Chattisgarh. 2021. Available From: http://rltrird.cg.gov.in/
[12]
Directorate General of Health Services 2021. Available from: https://dghs.gov.in/content/1418_1_CenterLeprosyeachingandResearchInstituteCent.aspx
[13]
Rao PN, Suneetha S. Current situation of leprosy in India and its future implications. Indian Dermatol Online J 2018; 9(2): 83-9.
[http://dx.doi.org/10.4103/idoj.IDOJ_282_17] [PMID: 29644191]
[14]
Antimicrobial Stewarship Program 2021. Available from: https://apps.who.int/iris/bitstream/handle/10665/329404/9789241515481-eng.pdf
[15]
Pai VV. Second-line anti-leprosy drugs: Indian experience. Indian J Drugs Dermatol 2020; 6(1): 1-4.
[http://dx.doi.org/10.4103/ijdd.ijdd_66_19]
[16]
Lazo-Porras M, Prutsky GJ, Barrionuevo P, et al. World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: A systematic review and meta-analysis. BMC Infect Dis 2020; 20(1): 62.
[http://dx.doi.org/10.1186/s12879-019-4665-0] [PMID: 31959113]
[17]
National Commission for the Incorporation of Technologies in the Unified Health System - CONITEC Media Consultations Reports 2021. Available From: https://www.gov.br/conitec/pt-br/midias/consultas/relatorios/2021/20211223_pcdt_hanseniase.pdf/view
[18]
Message for World Leprosy Day 2022. Available From: https://www.who.int/news/item/10-01-2022-message-for-world-leprosy-day-2022
[19]
Prabhu BP, Kunoor A, Sudhir S, et al. Antituberculosis treatment stewardship in a private tertiary care hospital in South India. Public Health Action 2018; 8(3): 151.
[http://dx.doi.org/10.5588/pha.18.0013] [PMID: 30271733]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy